Edward A Stadtmauer

5PUBLICATIONS
65CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 08, 2024
Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice.

Zainul S Hasanali, Alfred L Garfall, Lisa Burzenski

|Sep 28, 2023
Understanding Infection Risk with Anti-BCMA Bispecific Antibodies.

Alfred L Garfall, Edward A Stadtmauer

|Nov 22, 2022
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy.

Alfred L Garfall, Adam D Cohen, Sandra P Susanibar-Adaniya

|Aug 26, 2022
Changes in Bone Marrow Tumor and Immune Cells Correlate with Durability of Remissions Following BCMA CAR T Therapy in Myeloma.

Kavita M Dhodapkar, Adam D Cohen, Akhilesh Kaushal

|Feb 08, 2020
CRISPR-engineered T cells in patients with refractory cancer.

Edward A Stadtmauer, Joseph A Fraietta, Megan M Davis

Pageof 1